Steven Cohen’s Bright Minds Biosciences DRUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.6M Buy
372,481
+45,065
+14% +$3.18M 0.02% 956
2026
Q2
$23M Buy
+327,416
New +$25.7M 0.03% 805
2025
Q4
– Sell
-105,020
Closed -$6.37M – 3964
2025
Q3
$6.37M Sell
105,020
-30,000
-22% -$1.16M 0.01% 977
2025
Q2
$3.53M Hold
135,020
– – 0.01% 1089
2025
Q1
$4.87M Sell
135,020
-169
-0.1% -$6.19K 0.01% 936
2024
Q4
$4.87M Buy
+135,189
New +$4.76M 0.01% 953

Other funds holding DRUG

Steven Cohen's DRUG Position: Q3 2026 in Review

Steven Cohen increased its Bright Minds Biosciences (DRUG) stake by 14% in Q3 2026, buying an estimated $3.18M and bringing the position to 372,481 shares worth $18.6M. The position accounts for 0.02% of the portfolio, ranked #956.

Steven Cohen first reported a position in DRUG in Q4 2024 and has held it in 6 quarters since. The position peaked at $23M in Q2 2026. 109 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.

  • Steven Cohen held 372,481 shares of Bright Minds Biosciences worth $18.6M as of Q3 2026.
  • Steven Cohen bought 45,065 Bright Minds Biosciences shares in Q3 2026, an estimated $3.18M.
  • Bright Minds Biosciences made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #956 holding.
  • Steven Cohen first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Steven Cohen's Bright Minds Biosciences position peaked at $23M in Q2 2026.
  • 109 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.